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ABSTRACT:  After analyzing the Lauha Bhasma samples qualitatively and quantitatively,  in-
vivo studies on healthy adult male rabbits were carried out.  Randomly selected anaemic rabbits 
were divided into different groups and three variants of Lauha Bhasma and ferrous sulphate 
sample were administered to each group. The effect of each formulation was monitored by 
measuring the haemoglobin (Hb) content spectrophotometrically  (cyanomethaemoglobin 
method).  Increase in the haemoglobin content was found to be significant in case of the 
ayurvedic formulations as compared to the ferrous sulphate sample. 
 
INTRODUCTION 
 
On qualitative and quantitative analysis the 
samples of Lauha Bhasma were found to 
contain both the ferric and the ferrous iron, 
with greater proportion of ferric oxide than 
ferrous oxide (Verma et al., 1995). 
 
Normally in the allopathic system of 
medication the ferrous form of iron is given 
whereas in the ayurvedic system it is the 
ferric form. It is said that the ferrous form of 
iron is better absorbed than the ferric form in 
the gastrointestinal tract (Goodman and 
Gilman, 1975; Crossland, 1980). The 
ayurvedic system of medication claims that 
the iron preparation Lauha Bhasma is better 
absorbed gastroin testinally, hence 
biologically available, and is devoid of the 
usual side effects associated with the 
oral/parenteral iron preparations of the 
allopathic system of medication, Hence, it 
be comes of interest to compare the 
marketed ayurvedic and allopathic iron 
preparations on the basis of the increase in 
haemoglobin (Hb) content and the resulting 
bioavailabilities. 
 
METHODOLOGY 
 
Our of the number of methods available for 
determining the haemoglobin content,  the 
spectrophotometric method (cyanomethae 
moglobin method) was selected, as it was 
both accurate and reproducible, Blood, 
diluted suitably with cynanide-ferrocuamode 
reagent. Was measured at 540 nm (Varely, 
1980; Oser, 1971). In view of the slow 
reaction, the diluted blood was made to 
stand for 10 minutes to ensure complete 
conversion of the haemoglobin.  The 
haemoglobin content was caluculated was 
follows:  
Haemoglobin (g.dl) = A540 HiCN x 64,500 
x Diluting factor  
                                    44.00xdx1000x10 
where, 
A540 HiCN = absorbence of the solution at 
540 nm 64,500 = molecular weight of 
haemoglobin Dilution factor = 201 (when 20 
µl of blood diluted to 4 ml)   2 
44.0 = millimolar extinction coefficient  
d=Layer thickness in cm 
1000= Conversion factor (mg to gm) 
10 = Conversion factor (g/L to g/dl)  
 
 Induction of iron deficiency anaemia 
 
Healthy, adult, male rabbits were selected, 
having the weight range between 1.2 to 1.6 
kg. Thenormal Hb values of the healthy 
male rabbits were determined, which was 
found to be 10-14 g/dl.  The rabbits were put 
separately, in individual numbered cages. In 
order to induce iron deficiency anaemia, the 
rabbits were fed on a synthetic diet (Jha et 
al., 1968) and allowed to drink only double 
distilled iron free water. The diet was given 
in the quantity sufficient to give 200 calories 
/day/kg body weight till the haemoglobin 
content came down to the level 6-9 g/dl. 
 
Comparative efficacy studies of Lauha 
Bhasmas with ferrous sulphate 
 
Dried ferrous  sulphate was assayed and 
found  to contain 82% of ferrous sulphate, 
therefore, dose of 20 mg/day of the dried 
ferrous sulphate contained an equivalent of 6 
mg/day of the elemental iron. Upon assay 
Lauha Bhasma was found to contain 81 -
85% of the total iron (Verma et al., 1995). 
Thus the calculated equivalent dose of 10 
mg/day of Bhasma, was likely to contain 6 
mg/day of the elemental iron. 
 
The iron deficient anaemic rabbits were 
randomly selected and made into four 
groups each consisting of six rabbits, the 
animals were individually housed in 
numbered cages, along with the controlled 
synthetic diet, each group of animals was 
administered dried ferrous sulphate 
(20mg/day), HA Bhasma ordinary (10 
mg/day), Lauha Bhasma Satputti (10 
mg/day) and Lauha Bhasma Sahsatraputti 
(10 mg/day) respectively. 
 
The required dose was administered to seven 
days, and the blood samples collected 
subsequently on the 2
nd, 4
th, 6
th, and the 8
th 
day were analysed.  The data obtained are 
present in Table 1. 
 
The total increase in the haemoglobin 
content after administration of the drug was 
considered for the statistical evaluation. 
 
F-ratio test (Multiple comparison procedure)  
Analysis of Variance   
 
Sources of 
Variation 
Degree of 
Freedom 
Sum of 
Square 
Mean Square  F-ratio 
Among 
regiments 
t-1=3  24.727083  8.1560322   
Within 
regimens 
Σni-1  24.468097  S2=1.2234049  6.66666 
  
Test for significance  
 
The F-ratio is 4.94, as per F-Table (Osol, 
1980) with F1=t-1=3 and F2 = Σ (ni-1) =20 
degree of freedom. We find that the 
calculated F-ratio value 6.66666 is larger 
than the tabulated value 4.94 for P=0.01. 
 
Therefore, probability of these four samples 
being drawn from the same population was 
less than 0.01. Hence it was concluded that 
the four data obtained differ from each 
other. 
   3 
t-Test  
 
The t-test (Osol, 1980) was successfully 
employed  to find if the difference in data 
was significant (Table 2). 
 
Results  
 
The comparative bioavailability studies 
revealed that the ayurvedic iron preparation, 
Lauha Bhasma Sahastraputti and Lauha 
Bhasma Satputti, significantly increased the 
haemoglobin content of blood in the iron 
deficient anaetnic
 
 
Table -1 
 
HAEMOGLOBIN VALUES AFTER ADMINISTRATION OF FERROUS SULPHATE 
AND LAUHA BHASMA 
 
 
 
AVERAGE HAEMOGLOBIN CONTENT (g/dl)  Increased 
Hb Content 
(g/dl) 
 
Before 
synthetic 
diet 
After 
synthetic 
diet 
After administration of drug 
2
nd 
day 
4
th 
day 
6
th 
day 
8
th 
day 
Ferrous Sulphate  10.57 
10.86 
13.92 
12.19 
10.75 
13.12 
6.60 
6.27 
8.36 
8.15 
8.27 
8.71 
7.80 
7.81 
8.79 
8.27 
8376 
8.95 
8.53 
8.55 
8.56 
8.86 
9.41 
9.29 
9.06 
8.74 
9.62 
9.40 
9.65 
9.74 
10.45 
9.41 
9.73 
10.15 
10.29 
10.40 
3.85 
3.14 
1.37 
2.00 
2.02 
1.69 
Lauha Bhasmas  10.39 
10.60 
10.47 
11.22 
11.89 
12.39 
7.30 
8.61 
8.06 
7.39 
6.90 
7.96 
8.93 
9.21 
8.21 
7.98 
7.51 
7.96 
9.36 
9.57 
8.90 
8.53 
8.26 
8.59 
10.08 
10.21 
9.62 
9.03 
9.77 
9.80 
11.92 
10.97 
10.42 
9.80 
10.11 
10.50 
4.62 
2.36 
2.36 
2.41 
3.21 
3.30 
Satputti  10.23 
13.21 
11.86 
10.59 
12.81 
11.22 
7.21 
8.47 
6.83 
7.62 
6.21 
8.59 
7.27 
9.41 
9.60 
8.41 
7.38 
9.80 
7.99 
10.59 
10.80 
9.80 
8.21 
10.59 
8.51 
11.89 
11.78 
10.59 
9.60 
11.51 
9.53 
12.31 
12.81 
11.51 
10.42 
12.91 
2.02 
3.84 
5.35 
3.89 
4.21 
4.32 
Sahastra Putti  10.59 
11.22 
13.49 
11.53 
12.96 
10.23 
7.32 
8.56 
6.61 
7.52 
8.96 
6.95 
8.62 
11.50 
10.28 
8.27 
9.59 
8.26 
9.62 
12.64 
12.25 
9.20 
10.80 
9.65 
11.39 
13.16 
13.40 
10.48 
12.39 
10.50 
11.87 
13.63 
14.39 
11.24 
13.19 
11.94 
4.55 
5.07 
7.78 
3.72 
4.23 
4.99 
 
Rabbits, in comparison to the ferrous 
sulphate sample. The increase in the 
haemoglobin content due to ordinary Lauha 
Bhasma was not significant when compared 
to the ferrous sulphate sample. Also, 
amongst the three variants of Lauha   4 
Bhasma, the sahastraputti Bhasma was 
found to increase the haemoglobin content 
most significantly. 
 
Table -2 
STATISTICAL EVALUATION OF FERROUS SULPHATE AND THREE VARIANTS 
OF LAUHA BHASMA 
 
Case 
Number 
Sample 
No 
S
2  S  tcal  Two tail 
P=0.05 
t =2.228 
(as per t-table) 
One tail 
P=0.05 
t = 1.812 
(as per t-table) 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
1 Vs 4 
 
2 Vs 4 
 
3 Vs 4 
 
2 Vs 3 
 
1 Vs 3 
 
1 Vs 2 
1.46492 
 
1.04056 
 
0.87198 
 
0.98188 
 
1.40624 
 
1.60522 
1.2103421 
 
1.0200801 
 
0.9337986 
 
0.990899 
 
1.1858527 
 
1.266972 
3.30613 
 
2.7054 
 
1.29529 
 
1.5644 
 
2.94066 
 
1.52885 
Highly 
Significant 
Significant 
 
Not Significant  
 
Not Significant  
 
Significant  
 
Not Significant  
 
1>4 
 
2>4 
 
- 
 
- 
 
1>3 
 
Key: Sample 1 Sahastraputti; Sample 2 Satputti; Sample 3 Ordinary; Sample 4 Ferrous Sulphate 
 
DISCUSSION AND CONCLUSION  
 
The mucosal block hypothesis and the active 
transport hypothesis (Soine, 1967) Profess 
that iron is intestinally absorbed only in the 
ferrousform. Even the ferric form gets 
converted to the ferrous form before being 
absorbed.)  
 
According to the Iron Chelation Hy-pothesis 
(Saltman, 1965) either form of iron (Ferrous 
or ferric) is absorbed form the intestine. 
Therein the absorption of iron is exerted by 
the exorgenous or the endogenous ligands or 
chelating agents, these can bind either state 
of iron, to form low molecular weight 
complexes, capable of passively diffusing 
through the mucosal cell membrance of the 
intestine. 
 
Martin  (1981) have reported that both the 
ionic forms of iron are highly insoluble at 
neutral pH. The ferric iron reacts with low 
molecular weight compounds such as 
fructose, ascorbic acid, citric acid and amino 
acids toform complexes that allow ferric 
iron to remin soluble at the neutral pH of the 
intestinal fluid. 
 
The capacity to increase the haemoglobin 
content was more in Sahastraputti Bhasma, 
although the elemental iron content was 
same in all the samples taken, On analyzing 
the PSD data of Bhasma, the sahastraputti 
Bhasma was found to contain finer particles 
than the ordinary and the satputti Bhasma. 
As the rate of dissolution of smaller particles 
is usually faster than of the larger ones and 
is dependent on the specific surface area in 
contact with the liquid medium (Lackman   5 
and Lieberman, 1976), in our study it was 
observed that the specific surface area of 
sahastraputti was 4 times greater than that of 
the ordinary Lauha Bhasma (Verma et al., 
1995). Hence a higher rate of dissolution 
and a higher bioavailability may be expected 
form this sample. This is in conformity with 
the fact that the reduced iron is effective 
provided that the material employed has 
smaller particles (Elwood, 1968; Cook et al., 
1973). Satputti Lauha Bhasma was found to 
increase the haemoglobin content more 
significantly than the ferroussulphate 
sample. Although satputti Lauha  Bhasma 
was not found stastistically superior to the 
ferrous sulphate sample, probably due to the 
present of coarser particles in the sample, 
This holds good with the finding of Cook 
(1973) That iron having larger particles has 
much lower bioavailability. 
 
Conclusively, the ayurvedic iron preparation 
Sahastraputti Lauha Bhasma and satiputti 
Lauha Bhasma  may be considered to be 
better drugs that the allopathic iron 
preparation Ferrous sulphate, on the basis of 
the bioavailability resulting due to increase 
in the haemoglobin content. 
 
ACKNOWLEDGEMENT  
 
Authors are thankful to Dr. H.C Pande, the 
former director, Birla Institute of 
Technology, Mesra for providing financial 
assistance and Dr. B.K Razdan, Professor 
and Head, Department of Pharmaceutical 
sciences, Birla Institute of Technology, 
Mesra, Ranchi for providing required 
facilities and encouragement during the 
course of study. 
 
REFERENCES 
 
Cook J.D Minnich, V., Moore, C.V, Rasmussen, A., Bradly, W.B and Fich C.A (1973) 
Absorption of fortification iron in bread, American Journal of clinical Nutrition 26, 861-872. 
 
Crossland, J. (19801) Levis Pharmacology, 5
th edition Churchill Livingstone New York p. 660. 
Elwood, P.A. (1968) Radioactive studies of the absorption by human subjects of various iron 
preparation from bread. In, Iron in Flour. Ministry of Health report of Public health and 
Medicine, subject 117. Her Majesty’s stationary office, London p. 1-50. 
 
Goodman. L.S and Gilman, A. (1975) The Pharmacological Basis of Therapeutics 5
th edition, 
Macmillan Publishing company Inc, New York P.1310. 
 
Jha G.J Deo, M.G., Ramalingaswami, V. (1968) Bone growth in protein deficiency American 
journal of pathology 53 (6) p. 1111-1123. 
 
Lackman L., Liberman, H.A and Kanig J.L (1976) the Theory and Practice of Industrial 
Pharmacy, 2
nd edition, Lea & Febiger, p. 101. 
 
Martin, D.W Mayes P.A Rodwell V.W (1981) Harper’s Review of Biochemistry, 18
th edition, 
Lange Medical Publications California, p. 559 Oser B.L (1971)  
 
Howk’s Physiological chemistry, 14
th edition, Tata McGraw Hill Publishing co. Ltd Ne Delhi 
p/1091-1097. 
   6 
Osal, A. (1980) Remington’s Pharmaceutical sciences, 16
th edition Mach Publishing Co. Easton, 
Pennsylvania p. 113-119. 
 
Saltman P. (1965) The role of chelation in iron metabolism journal of chem. Ed 42:682. 
 
Soine, T.O., Wilson Co (1967) Rogers’ Inorganic Pharmaceutical chemistry, 8
th edition Lae & 
Febiger Philadelphia, P 612. 
 
Varley H., Gowenlok, A.H Bell M. (1980) Practical clinical Biochemistry, Vol I 5
th edition 
William Hainemann Medical Book Ltd London p. 979-981. 
 
Verma, P.R.P and Prasad, C.M (0995) standardization and bioavailability of Ayurvedic drug 
Lauha Bhasma I Physical and chemical evaluation. Ancient Sci of Life 15, 129-136. 
 
 
 
 
 
 
 
 
  
 
 